Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study

Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib–Irinotecan Combo: A Case Study

Kailin Ding,1,* Xian Chen,2,* Yong Li,2 Wenzhu Li,2 Yongsong Ye,3 Tingting He,4 Wenjing Wang,4 Haibo Zhang2 1The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China; 2Department of Oncology, The Second Affiliated Hospital of Guangzhou Un...

Full description

Bibliographic Details
Main Authors: Ding K, Chen X, Li Y, Li W, Ye Y, He T, Wang W, Zhang H
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:OncoTargets and Therapy
Subjects:
erbb3
gastric cancer
irinotecan
pyrotinib
third-line therapy.
Online Access:https://www.dovepress.com/gastric-cancer-harboring-an-erbb3-mutation-treated-with-a-pyrotinibnda-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/gastric-cancer-harboring-an-erbb3-mutation-treated-with-a-pyrotinibnda-peer-reviewed-article-OTT

Similar Items